![]() Both fixed effects and random effects models were used to analyze the extracted data.The frequentist weighted regression-based NMA was performed in R v4.1.2 using the netmeta package 3.Measures of health-related quality of life, breathlessness, rescue medication use, exacerbations, and symptom severity were investigated, but are not presented on this poster.Data were extracted for change from baseline in trough forced expiratory volume in 1 second (FEV 1) at 24 and 12 weeks Long-acting bronchodilators, including long-acting 2 agonists (LABAs) and long-acting muscarinic antagonists (LAMAs), are the mainstay of treatment for.RCTs ≥8 weeks in adult patients with COPD that compared LAMA/LABA combinations with any long-acting bronchodilator-containing dual or monotherapy were identified ( Figure 1). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |